Moreover, since the CLL/SLL developed by the Traf2DNxBCL2-tg+/+ mice may express or not CD5 on their surface (22), this could reflect that MZ B cells were at different activation stage at the time of transformation [reviewed in (2)]. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.